ARCELLX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.36 USD | +1.38% |
|
+9.22% | -2.05% |
| May. 15 | Stifel Adjusts Price Target on Arcellx to $83 From $82, Maintains Buy Rating | MT |
| May. 14 | Evercore ISI Starts Arcellx With Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARCELLX, INC. | Other Biotechnology & Medical Research | +1.38% | +9.22% | -2.05% | +31.27% | - | 2.91B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ACLX Stock
- Charts Arcellx, Inc.
- Comparison Chart
